| Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs F Ranchon, G Salles, HM Späth, V Schwiertz, N Vantard, S Parat, ... BMC cancer 11, 1-10, 2011 | 161 | 2011 |
| Analysis of the eligibility of published economic evaluations for transfer to a given health care system: methodological approach and application to the French health care system HM Späth, MO Carrère, B Fervers, T Philip Health Policy 49 (3), 161-177, 1999 | 69 | 1999 |
| Economic impact of harmonizing medical practices: compliance with clinical practice guidelines in the follow-up of breast cancer in a French Comprehensive Cancer Center D Mille, T Roy, MO Carrère, I Ray, N Ferdjaoui, HM Späth, F Chauvin, ... Journal of clinical oncology 18 (8), 1718-1724, 2000 | 67 | 2000 |
| Role of clinical, patient-reported outcome and medico-economic studies in the public hospital drug formulary decision-making process: results of a European survey E Haslé-Pham, B Arnould, HM Späth, A Follet, G Duru, P Marquis Health Policy 71 (2), 205-212, 2005 | 43 | 2005 |
| A qualitative approach to the use of economic data in the selection of medicines for hospital formularies: a French survey HM Späth, M Charavel, M Morelle, MO Carrere Pharmacy World and Science 25, 269-275, 2003 | 42 | 2003 |
| Economic burden of seasonal influenza B in France during winter 2010-2011 ML Silva, L Perrier, HM Späth, I Grog, A Mosnier, N Havet, JM Cohen BMC public health 14, 1-10, 2014 | 25 | 2014 |
| A literature review to identify factors that determine policies for influenza vaccination ML Silva, L Perrier, JM Cohen, WJ Paget, A Mosnier, HM Späth Health Policy 119 (6), 697-708, 2015 | 23 | 2015 |
| Cost-effectiveness of treatments for mild-to-moderate obstructive sleep apnea in France AI Poullié, M Cognet, A Gauthier, M Clementz, S Druais, HM Späth, ... International Journal of Technology Assessment in Health Care 32 (1-2), 37-45, 2016 | 18 | 2016 |
| Systematic literature review of economic evaluations of biological treatment sequences for patients with moderate to severe rheumatoid arthritis previously treated with disease … S Ghabri, L Lam, F Bocquet, HM Spath Pharmacoeconomics 38 (5), 459-471, 2020 | 17 | 2020 |
| Determinants of medical direct costs of care among patients of a memory center V Dauphinot, A Garnier-Crussard, C Moutet, F Delphin-Combe, HM Späth, ... The Journal of Prevention of Alzheimer's Disease 8, 351-361, 2021 | 11 | 2021 |
| L'utilisation de l'information économique dans le secteur de la santé: le choix des médicaments à inclure dans les livrets thérapeutiques hospitaliers HM Spath, B Allenet, MO Carrère Journal d'économie médicale 18 (3-4), 147-161, 2000 | 9 | 2000 |
| Influenza vaccination policy-making processes in France and The Netherlands: Framework and determinants ML Silva, L Perrier, JW Paget, A Mosnier, V Buthion, JM Cohen, HM Späth Health Policy 120 (3), 293-305, 2016 | 8 | 2016 |
| Comparison of health technology assessment for new medicines in France and England: an example based on ixazomib for patients with relapsed or refractory multiple myeloma X Armoiry, HM Spath, A Clarke, M Connock, P Sutcliffe, C Dussart Journal of Market Access & Health Policy 7 (1), 1648971, 2019 | 7 | 2019 |
| Intégration des critères économiques dans les recommandations pour la pratique clinique en cancérologie B Fervers, HM Spath, T Philip, MO CARRERE Bulletin du cancer 85 (3), 272-280, 1998 | 7 | 1998 |
| Development of seasonal influenza vaccination recommendations: relevance and influence of the evidence on the decision-making process in France and the Netherlands ML Silva, WJ Paget, A Mosnier, V Buthion, JM Cohen, L Perrier, HM Späth Value in Health 19 (5), 670-679, 2016 | 5 | 2016 |
| Cost-effectiveness analysis of active TDM in elderly patients treated with aminoglycosides CB Leon-Djian, L Bourguignon, HM Späth, P Maire Therapie 66 (5), 445-452, 2011 | 5 | 2011 |
| L'aide à la décision apportée par l'information économique dans le secteur de la santé: le choix des médicaments à inclure dans les livrets thérapeutiques d'établissements … HM Späth Lyon 1, 2001 | 5 | 2001 |
| The use of economic evaluations in health decision-making at the macro level: a literature review ML Silva, HM Späth, L Perrier, N Moumjid Journal de gestion et d’économie médicales 31 (1), 31-52, 2013 | 4 | 2013 |
| Quelle place pour l’évaluation clinique et médico-économique des dispositifs médicaux à usage individuel? F Taboulet, HM Späth Droit et économie pharmaceutiques: prospectives 2005, 277-304, 2005 | 4 | 2005 |
| Systematic literature review on implicit factors influencing the HTA deliberative processes in Europe C Monleón, HM Späth, C Crespo, C Dussart, M Toumi Journal of Market Access & Health Policy 10 (1), 2094047, 2022 | 3 | 2022 |
